Stem cell clinical trial aims to combat nerve damage in human tissue

Hi! Today, i talk about of this article.

The idea is inject embryonic stem cell to a patient with a damaged spinal cord. The trial was accepted by the US Food and Drug Administration in January last year, and actually is being organized by the biotech company Geron in California.
The patient with damaged spinal cord was treated on Friday in Atlanta, in a centre of the company Geron. Doctors hope that stem cells injected directly into the spine will help repair the damage to person recovery some movement. Fourteen days later, patient will be injected with living cell that are precoursors of a kind found in the nervous system.
There was test in animals that indicate that injections with stem cells improve their movement and they can walk after sustaining an injury.

Throughout the test, doctors monitor patients for see if you are recovering a sense or are able to move parts of the body affected by injury.
The doctors commented that when they began to research , many thought it would take several decades before this therapy would be approved for use in humans.
The trial had problems with religious groups because the cells are derived from spare embryos created at IVF clinics but doctors said that trial is safe and the investigation was acepted by all the organisms.

The director of the MRC Centre for Regenerative Medicine at Edinburgh University, said that although this is very exciting news, it is important to note that the goal of testing is no harm to the patient instead of seeking profits, and after obtaining the results, the focus can shift to the development and evaluation of new treatment.